Shares of Canadian cannabis company Tilray Inc. were up 2.4% Wednesday in higher-than-average volume, on speculation surrounding an expected House vote this week on a bill that could decriminalize cannabis. The bill, called the Marijuana Opportunity Reinvestment and Expungement Act, or MORE Act, would remove cannabis from the Schedule I classification that has long kept on an equal footing with heroin, even as many states have moved to legalize it for medical or recreational use. The speculation Read More...
Shares of Canadian cannabis company Tilray Inc. were up 2.4% Wednesday in higher-than-average volume, on speculation surrounding an expected House vote this week on a bill that could decriminalize cannabis. The bill, called the Marijuana Opportunity Reinvestment and Expungement Act, or MORE Act, would remove cannabis from the Schedule I classification that has long kept on an equal footing with heroin, even as many states have moved to legalize it for medical or recreational use. The speculation
Add Comment